Molative Paediatric

Sodium hydrogen carbonate, the active ingredient in Molative Paediatric, is an electrolyte component presented as an oral powder for oral use. It helps restore electrolyte balance and supports bowel function in children. GNH USA supplies Molative Paediatric as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Molative Paediatric is used in pediatric care to address electrolyte disturbances and bowel motility disorders. - Constipation: softens stool and promotes regular bowel movements in children. - Bowel preparation: clears the colon before diagnostic procedures such as endoscopy. - Electrolyte replacement: provides sodium, potassium and chloride to aid rehydration in mild dehydration.

Molative Paediatric may be associated with several adverse reactions.

Common Side Effects: - Abdominal bloating or distension - Flatulence - Nausea - Mild diarrhea - Transient electrolyte imbalance (e.g., mild hypernatremia)

Serious or Rare Side Effects: - Severe dehydration - Allergic reactions (rash, itching, swelling) - Significant electrolyte disturbances (hypernatremia, hyperkalemia) - Intestinal obstruction or perforation in susceptible patients

Use Molative Paediatric with caution and under medical supervision. - Assess baseline electrolyte status: check serum sodium and potassium before initiating therapy. - Pediatric supervision required: dosage and duration must be prescribed by a qualified clinician. - Monitor for signs of dehydration or over‑hydration during treatment. - Avoid in patients with known hypersensitivity to any component. - Adjust use in renal impairment: consult a physician for appropriate monitoring. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Molative Paediatric can interact with other medicines that affect fluid and electrolyte balance.

Major Interactions (Avoid): - Concurrent use of other osmotic laxatives may cause severe electrolyte loss. - Co‑administration with sodium‑containing intravenous fluids can precipitate hypernatremia. - Use with potassium‑sparing diuretics may lead to hyperkalemia.

Moderate Interactions (Monitor Closely): - Antacids may alter the absorption of sodium hydrogen carbonate. - Non‑steroidal anti‑inflammatory drugs (NSAIDs) can increase the risk of renal impairment when combined. - ACE inhibitors or ARBs may require closer monitoring of potassium levels.